Older Adults With Type 2 Diabetes

Risks & contraindications

Other

Other

Other

Highlighted claims

• The final study cohort contained 133,773 older adults with type 2 diabetes and A1C at or below 7.0%. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
• The index date was the first eligible A1C test of 7.0% or lower during the study period. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
• The cohort included community-dwelling adults over 75 and long-term care residents over 65 with type 2 diabetes and controlled A1C values. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
• Patients receiving palliative care and patients missing physician information for the index A1C test were excluded. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
• Intensive glucose lowering is especially important in older adults because benefits decline with age while risks increase. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study